Andrew Kozlov
Andrew Kozlov has a total of 163 co-authors. Here are the top co-authors by number of shared publications:
- Mikhail V. Galkin
Burdenko Neurosurgical Center
7 shared publications - Vasilii A. Cherekaev
Federal State Autonomous Institution «N. N. Burdenko National Medical Research Center of Neurosurgery» of the Ministry of Health of the Russian Federation, 16, 4th Tverskaya-Yamskaya St., Moscow, Russia
7 shared publications - A. B. Kadasheva
Burdenko Neurosurgical Center
5 shared publications - Andrey V. Golanov
N.N. Burdenko National Medical Research Center of Neurosurgery, Ministry of Health of Russia
5 shared publications - Nikolay V. Lasunin
Burdenko Neurosurgical Center
5 shared publications - Nadezhda N. Grigorieva
Burdenko Neurosurgical Center
4 shared publications
Latest Publications
- 7 August 2026
- Published by Media Sphere Publishing Group in Burdenko's Journal of Neurosurgery
- Vol. 90 (4)
Contralateral venous thrombosis and intracerebral hemorrhage after resection of parasagittal meningioma: a case report and systematic review
Background. Preservation of venous structures and prevention of cortical trauma during resection of parasagittal meningioma are key factors ensuring high quality after surgery. However, venous circulatory disorders are possible despite these principles. Objective. To describe contralateral cerebral venous thrombosis and compare own findings with literature data on cerebral venous thrombosis in parasagittal meningioma. Results and discussion. A 53-year-old man with parasagittal meningioma of posterior third of superior sagittal sinus bordering the middle third on the right developed local thrombosis of sinus and parietal vein, as well as contralateral secondary intracerebral hemorrhage in 9 days after surgery. We did not remove tumor remnant inside the sinus. Superior sagittal sinus was not opened. Meningioma matrix coagulation was performed using direct spray mode. Enoxaparin sodium (subsequently switched to rivaroxaban) and citicoline were prescribed. The Karnofsky score recovered to 90 points after 3 months. In accordance with the PRIZMA recommendations, we reviewed the PubMed and Google Scholar databases using the keywords «parasagittal AND meningioma AND venous AND thrombosis». We found 12 and 2.540 manuscripts, respectively. Analysis of all abstracts in PubMed database and 200 most relevant papers in Google Scholar database identified 3 eligible reports. Clearly, such complications are extremely rare. Conclusion. Contralateral thrombosis of bridging vein after resection of parasagittal meningioma is unique and deserves attention. Timely diagnosis and anticoagulation can lead to complete regression of neurological symptoms.
- 7 August 2026
- Published by Media Sphere Publishing Group in Burdenko's Journal of Neurosurgery
- Vol. 90 (4)
Contralateral venous thrombosis and intracerebral hemorrhage after resection of parasagittal meningioma: a case report and systematic review
Background. Preservation of venous structures and prevention of cortical trauma during resection of parasagittal meningioma are key factors ensuring high quality after surgery. However, venous circulatory disorders are possible despite these principles. Objective. To describe contralateral cerebral venous thrombosis and compare own findings with literature data on cerebral venous thrombosis in parasagittal meningioma. Results and discussion. A 53-year-old man with parasagittal meningioma of posterior third of superior sagittal sinus bordering the middle third on the right developed local thrombosis of sinus and parietal vein, as well as contralateral secondary intracerebral hemorrhage in 9 days after surgery. We did not remove tumor remnant inside the sinus. Superior sagittal sinus was not opened. Meningioma matrix coagulation was performed using direct spray mode. Enoxaparin sodium (subsequently switched to rivaroxaban) and citicoline were prescribed. The Karnofsky score recovered to 90 points after 3 months. In accordance with the PRIZMA recommendations, we reviewed the PubMed and Google Scholar databases using the keywords «parasagittal AND meningioma AND venous AND thrombosis». We found 12 and 2.540 manuscripts, respectively. Analysis of all abstracts in PubMed database and 200 most relevant papers in Google Scholar database identified 3 eligible reports. Clearly, such complications are extremely rare. Conclusion. Contralateral thrombosis of bridging vein after resection of parasagittal meningioma is unique and deserves attention. Timely diagnosis and anticoagulation can lead to complete regression of neurological symptoms.
- 30 December 2025
- Published by Media Sphere Publishing Group in Burdenko's Journal of Neurosurgery
- Vol. 89 (6) , 21-28
Hypofractionated irradiation for intracranial meningiomas
Hypofractionated irradiation of meningiomas is a relevant fractionation regimen that occupies an intermediate position between radiosurgery and standard fractionation. This study analyzed the experience with this regimen in the Radiotherapy Department of the Burdenko National Medical Research Center of Neurosurgery to evaluate the method’s efficacy and safety. A retrospective analysis included patients who underwent radiation therapy between 2017 and 2020. The study included 73 patients. The median age was 56, and the male-to-female ratio was 1:5. Nine patients were diagnosed with schwannomatosis (neurofibromatosis type 2), and 12 had multiple meningiomas. A total of 94 meningiomas were treated with hypofractionation in regimens of 3 and 5 fractions. Twenty eight tumors (29.8%) were previously verified as WHO grade 1 (25) and grade 2 (3). The median target volume was 5.6 cm³ (range 0.2 to 28.9 cm³). Data for analysis were available for 60 patients with 80 tumors, which did not differ significantly in baseline characteristics from the entire group. The local 3-year and 5-year control rate for meningiomas was 95%. Local control did not differ between sporadic tumors and those associated with schwannomatosis and multiple meningiomas. Tumor control was not influenced by volume, number of fractions, dose, treatment platform, histological verification status, or tumor location (skull base vs. convexity). Radiation reactions within 12 months after treatment were detected in 5 tumors (6.3%). The presence of pre-existing peritumoral edema significantly increased the risk of radiation reactions to 60%. A reduction in meningioma size was observed in 61.3% of cases. The median tumor volume reduction was 37% (range 8—84%). This study identified 2 cases (2.5%) of radiation-induced pathomorphosis in the form of appearance and prolonged existence/progression of cysts, which is generally an uncharacteristic clinical course for meningiomas. Thus, hypofractionation is an effective and sufficiently safe method of radiation therapy for meningiomas, enabling the more frequent use of shortened radiation treatment courses instead of prolonged standard fractionation regimens. Given the rare recurrence of meningiomas and the low complication rate, larger and longer-term studies are needed to clarify all factors influencing the outcomes of radiation therapy.
- 30 December 2025
- Published by Media Sphere Publishing Group in Burdenko's Journal of Neurosurgery
- Vol. 89 (6) , 21-28
Hypofractionated irradiation for intracranial meningiomas
Hypofractionated irradiation of meningiomas is a relevant fractionation regimen that occupies an intermediate position between radiosurgery and standard fractionation. This study analyzed the experience with this regimen in the Radiotherapy Department of the Burdenko National Medical Research Center of Neurosurgery to evaluate the method’s efficacy and safety. A retrospective analysis included patients who underwent radiation therapy between 2017 and 2020. The study included 73 patients. The median age was 56, and the male-to-female ratio was 1:5. Nine patients were diagnosed with schwannomatosis (neurofibromatosis type 2), and 12 had multiple meningiomas. A total of 94 meningiomas were treated with hypofractionation in regimens of 3 and 5 fractions. Twenty eight tumors (29.8%) were previously verified as WHO grade 1 (25) and grade 2 (3). The median target volume was 5.6 cm³ (range 0.2 to 28.9 cm³). Data for analysis were available for 60 patients with 80 tumors, which did not differ significantly in baseline characteristics from the entire group. The local 3-year and 5-year control rate for meningiomas was 95%. Local control did not differ between sporadic tumors and those associated with schwannomatosis and multiple meningiomas. Tumor control was not influenced by volume, number of fractions, dose, treatment platform, histological verification status, or tumor location (skull base vs. convexity). Radiation reactions within 12 months after treatment were detected in 5 tumors (6.3%). The presence of pre-existing peritumoral edema significantly increased the risk of radiation reactions to 60%. A reduction in meningioma size was observed in 61.3% of cases. The median tumor volume reduction was 37% (range 8—84%). This study identified 2 cases (2.5%) of radiation-induced pathomorphosis in the form of appearance and prolonged existence/progression of cysts, which is generally an uncharacteristic clinical course for meningiomas. Thus, hypofractionation is an effective and sufficiently safe method of radiation therapy for meningiomas, enabling the more frequent use of shortened radiation treatment courses instead of prolonged standard fractionation regimens. Given the rare recurrence of meningiomas and the low complication rate, larger and longer-term studies are needed to clarify all factors influencing the outcomes of radiation therapy.
- 16 October 2025
- Published by Media Sphere Publishing Group in Burdenko's Journal of Neurosurgery
- Vol. 89 (5) , 79-86
Influence of surgical access on bacterial contamination of autologous blood in neurosurgical patients
All perioperative invasive procedures, including those associated with autologous blood circulation in extracorporeal circuit, should be considered as a risk factor of infectious complications. Despite perioperative antibiotic prophylaxis and compliance with standards for hardware reinfusion in neurosurgical interventions, bacterial contamination of autologous blood occurs in 38.3% of cases. One of the risk factors may be surgical approach. Objective. To analyze the influence of surgical access on bacterial contamination of autologous blood and effectiveness of complex decontamination in hardware reinfusion in neurosurgery. Material and methods. The study included 107 patients with CNS tumors and high risk of intraoperative blood loss with hardware blood reinfusion. Three surgical approaches were used: transcranial, extended transcranial with opening of paranasal sinuses and transnasal endoscopic access. The protocol of perioperative antibiotic prophylaxis was used in all patients. We evaluated bacterial contamination after decontamination using microbiological testing. Results. Surgical approach significantly affected the risk of bacterial contamination of autologous blood in neurosurgical patients (p<0.001). The minimum risk was observed for transcranial approaches (29%), moderate — for extended transcranial approaches (50%), maximum — for transnasal endoscopic approaches (100%). This pattern is not presented in available literature. There were no local or systemic infectious complications in postoperative period. Conclusion. Transfusion of autologous blood is quite safe in case of appropriate perioperative antibiotic prophylaxis and all measures aimed at blood decontamination. Approaches with opening the paranasal sinuses require 4-stage decontamination (cefuroxime+washing+leukofiltration+irradiation).
- 16 October 2025
- Published by Media Sphere Publishing Group in Burdenko's Journal of Neurosurgery
- Vol. 89 (5) , 79-86
Influence of surgical access on bacterial contamination of autologous blood in neurosurgical patients
All perioperative invasive procedures, including those associated with autologous blood circulation in extracorporeal circuit, should be considered as a risk factor of infectious complications. Despite perioperative antibiotic prophylaxis and compliance with standards for hardware reinfusion in neurosurgical interventions, bacterial contamination of autologous blood occurs in 38.3% of cases. One of the risk factors may be surgical approach. Objective. To analyze the influence of surgical access on bacterial contamination of autologous blood and effectiveness of complex decontamination in hardware reinfusion in neurosurgery. Material and methods. The study included 107 patients with CNS tumors and high risk of intraoperative blood loss with hardware blood reinfusion. Three surgical approaches were used: transcranial, extended transcranial with opening of paranasal sinuses and transnasal endoscopic access. The protocol of perioperative antibiotic prophylaxis was used in all patients. We evaluated bacterial contamination after decontamination using microbiological testing. Results. Surgical approach significantly affected the risk of bacterial contamination of autologous blood in neurosurgical patients (p<0.001). The minimum risk was observed for transcranial approaches (29%), moderate — for extended transcranial approaches (50%), maximum — for transnasal endoscopic approaches (100%). This pattern is not presented in available literature. There were no local or systemic infectious complications in postoperative period. Conclusion. Transfusion of autologous blood is quite safe in case of appropriate perioperative antibiotic prophylaxis and all measures aimed at blood decontamination. Approaches with opening the paranasal sinuses require 4-stage decontamination (cefuroxime+washing+leukofiltration+irradiation).
- 27 August 2025
- Published by Media Sphere Publishing Group in Burdenko's Journal of Neurosurgery
- Vol. 89 (4) , 87-97
Malignancy of fibrous dysplasia of the calvarial bone in patient with McCune-Albright syndrome: clinical observation and literature review
Malignant transformation of fibrous dysplasia in McCune-Albright syndrome is observed in less than 1% of cases, thus osteosarcoma is developing more frequently. According to the search in the PubMed database over the last 5 years, 13 publications were found, but none of them described cerebral cranium damage. Material and methods. A clinical observation of a 27-year-old patient with polyostotic fibrous dysplasia, skin manifestations and prolactin+HGH-secreting pituitary adenoma — McCune-Albright syndrome — without GNAS gene mutation is described. The patient had a rapidly increasing formation in the left temporoparietal region, which reached 18×20×15 cm, accompanied by local pain and fever 4 months prior to hospitalization. Diagnosis of osteosarcoma was verified by biopsy. Neoadjuvant chemotherapy in the presence of intracranial hypertension and giant tumor has been refused. Results. Preoperative embolization of tumor vessels with polyvinyl alcohol emboli was moderately effective. Tumor node has been removed, blood loss amounted to 5500 ml, blood autodonation, cell saver, 1 dose of donor erythrocytes were used. On the 1st day, the patient was transferred to the clinical unit, pain and fever ceased. He was discharged on the 8th day in satisfactory condition. Nevertheless, chemotherapy in the home area was not performed and the patient died from the disease progression in 1.5 months. The algorithm of care in osteosarcoma — neoadjuvant chemotherapy, tumor resection and adjuvant treatment. However, the results of such treatment remain generally unsatisfactory. The algorithm of treatment for patients with fibrous dysplasia malignancy in McCune-Albright syndrome is not presented in the literature. The surgical intervention resulted in the removal of the main tumor volume and regression of intracranial hypertension, but did not significantly affect the patient’s fate in the absence of adjuvant chemotherapy. Conclusion. The possibility of malignant neoplasms development from fibrous dysplasia in McCune-Albright syndrome must be taken into consideration. The development of an algorithm for care in such patients requires accumulation of material and its analysis.
- 27 August 2025
- Published by Media Sphere Publishing Group in Burdenko's Journal of Neurosurgery
- Vol. 89 (4) , 87-97
Malignancy of fibrous dysplasia of the calvarial bone in patient with McCune-Albright syndrome: clinical observation and literature review
Malignant transformation of fibrous dysplasia in McCune-Albright syndrome is observed in less than 1% of cases, thus osteosarcoma is developing more frequently. According to the search in the PubMed database over the last 5 years, 13 publications were found, but none of them described cerebral cranium damage. Material and methods. A clinical observation of a 27-year-old patient with polyostotic fibrous dysplasia, skin manifestations and prolactin+HGH-secreting pituitary adenoma — McCune-Albright syndrome — without GNAS gene mutation is described. The patient had a rapidly increasing formation in the left temporoparietal region, which reached 18×20×15 cm, accompanied by local pain and fever 4 months prior to hospitalization. Diagnosis of osteosarcoma was verified by biopsy. Neoadjuvant chemotherapy in the presence of intracranial hypertension and giant tumor has been refused. Results. Preoperative embolization of tumor vessels with polyvinyl alcohol emboli was moderately effective. Tumor node has been removed, blood loss amounted to 5500 ml, blood autodonation, cell saver, 1 dose of donor erythrocytes were used. On the 1st day, the patient was transferred to the clinical unit, pain and fever ceased. He was discharged on the 8th day in satisfactory condition. Nevertheless, chemotherapy in the home area was not performed and the patient died from the disease progression in 1.5 months. The algorithm of care in osteosarcoma — neoadjuvant chemotherapy, tumor resection and adjuvant treatment. However, the results of such treatment remain generally unsatisfactory. The algorithm of treatment for patients with fibrous dysplasia malignancy in McCune-Albright syndrome is not presented in the literature. The surgical intervention resulted in the removal of the main tumor volume and regression of intracranial hypertension, but did not significantly affect the patient’s fate in the absence of adjuvant chemotherapy. Conclusion. The possibility of malignant neoplasms development from fibrous dysplasia in McCune-Albright syndrome must be taken into consideration. The development of an algorithm for care in such patients requires accumulation of material and its analysis.
- 4 April 2025
- Published by Media Sphere Publishing Group in Burdenko's Journal of Neurosurgery
- Vol. 89 (2) , 97-103
Venous factor in surgical management of skull base meningiomas
Skull base venous system is a variable anatomical formation in both health and pathology. Damage to venous structures during surgical treatment of craniobasal meningiomas can lead to formidable postoperative complications, such as hemorrhagic infarctions, cerebral edema and persistent neurological deficit. Despite the improvement of microsurgical techniques, methods of morphological and functional angiography, as well as modeling the mechanisms of compensation for venous hemodynamic disorders, the problem of preventing postoperative venous complications remains relevant. Objective. To analyze available literature data on the role of venous system in surgery for skull base meningiomas and prevention of venous outflow disorders. Material and methods. The PRISMA algorithm was used to search for publications on venous complications, venous outflow compensation and prevention of vein damage in skull base meningiomas. The PubMed and Google Scholar databases were reviewed. Results. Thirty-six manuscripts were assessed. Statistics of venous complications in neurosurgery, venous system reorganization in craniobasal meningiomas, modern methods of X-ray diagnosis and minimization of venous complications during tumor resection are described. Conclusion. Peculiarities of venous hemodynamics in skull base meningiomas are important in planning surgical treatment, as evidenced by many studies in recent years. Improvement of microsurgical techniques and highly informative methods of X-ray diagnosis reduce the likelihood of venous complications in neurosurgery. However, persistent risk of vein damage during resection of craniobasal meningiomas necessitates further improvement of diagnostic and treatment algorithms.
- 4 April 2025
- Published by Media Sphere Publishing Group in Burdenko's Journal of Neurosurgery
- Vol. 89 (2) , 97-103
Venous factor in surgical management of skull base meningiomas
Skull base venous system is a variable anatomical formation in both health and pathology. Damage to venous structures during surgical treatment of craniobasal meningiomas can lead to formidable postoperative complications, such as hemorrhagic infarctions, cerebral edema and persistent neurological deficit. Despite the improvement of microsurgical techniques, methods of morphological and functional angiography, as well as modeling the mechanisms of compensation for venous hemodynamic disorders, the problem of preventing postoperative venous complications remains relevant. Objective. To analyze available literature data on the role of venous system in surgery for skull base meningiomas and prevention of venous outflow disorders. Material and methods. The PRISMA algorithm was used to search for publications on venous complications, venous outflow compensation and prevention of vein damage in skull base meningiomas. The PubMed and Google Scholar databases were reviewed. Results. Thirty-six manuscripts were assessed. Statistics of venous complications in neurosurgery, venous system reorganization in craniobasal meningiomas, modern methods of X-ray diagnosis and minimization of venous complications during tumor resection are described. Conclusion. Peculiarities of venous hemodynamics in skull base meningiomas are important in planning surgical treatment, as evidenced by many studies in recent years. Improvement of microsurgical techniques and highly informative methods of X-ray diagnosis reduce the likelihood of venous complications in neurosurgery. However, persistent risk of vein damage during resection of craniobasal meningiomas necessitates further improvement of diagnostic and treatment algorithms.
- 5 February 2025
- Published by Media Sphere Publishing Group in Burdenko's Journal of Neurosurgery
- Vol. 89 (1) , 20-29
En plaque convexity hyperostotic meningioma: 69 cases from a singlecenter
Background. To date, 16 cases of en plaque hyperostotic meningioma of the convexity have been described. There are no clinical guidelines for the treatment of such patients. Objective. To study the factors influencing the results of surgical treatment of en plaque convexity hyperostotic meningioma, to formulate the appropriate decision-making algorithm. Material and methods. A retrospective total group of 69 patients with en plaque convexity hyperostotic meningioma who underwent surgery at Burdenko Neurosurgical Center between 2014 and 2023. We analyzed clinical manifestations, tactics and results of surgery and radiotherapy using statistical methods. Results and discussion. Total resection of small local non-infiltrative hyperostotic meningioma not involving the superior sagittal sinus did not cause neurological deterioration. In case of spread infiltrative hyperostotic meningiomas, the best results (including regression of intracranial hypertension in all cases) were obtained after non-radical surgeries (resection of hyperostosis without wide excision of the dura or even without dura opening). Extent of resection of involved dura and intracranial tumor did not affect relapse-free survival. Additional morbidity at discharge from the clinic was 35%, after ≥6 months — 16%. The most common (27.5%) complication was pseudomeningocele. Redo surgery rate for pseudomeningocele — 7%, hematomas — 7%, wound infection — 6%. There were no mortality in the series. Radiotherapy increased relapse-free survival without statistical confirmation. Conclusion. Total resection provides optimal results in patients with small convexity hyperostotic meningioma and no brain invasion. Resection of hyperostosis and expansive cranioplasty are preferable for large and giant convexity hyperostotic meningioma involving venous sinuses and / or the brain.
- 5 February 2025
- Published by Media Sphere Publishing Group in Burdenko's Journal of Neurosurgery
- Vol. 89 (1) , 20-29
En plaque convexity hyperostotic meningioma: 69 cases from a singlecenter
Background. To date, 16 cases of en plaque hyperostotic meningioma of the convexity have been described. There are no clinical guidelines for the treatment of such patients. Objective. To study the factors influencing the results of surgical treatment of en plaque convexity hyperostotic meningioma, to formulate the appropriate decision-making algorithm. Material and methods. A retrospective total group of 69 patients with en plaque convexity hyperostotic meningioma who underwent surgery at Burdenko Neurosurgical Center between 2014 and 2023. We analyzed clinical manifestations, tactics and results of surgery and radiotherapy using statistical methods. Results and discussion. Total resection of small local non-infiltrative hyperostotic meningioma not involving the superior sagittal sinus did not cause neurological deterioration. In case of spread infiltrative hyperostotic meningiomas, the best results (including regression of intracranial hypertension in all cases) were obtained after non-radical surgeries (resection of hyperostosis without wide excision of the dura or even without dura opening). Extent of resection of involved dura and intracranial tumor did not affect relapse-free survival. Additional morbidity at discharge from the clinic was 35%, after ≥6 months — 16%. The most common (27.5%) complication was pseudomeningocele. Redo surgery rate for pseudomeningocele — 7%, hematomas — 7%, wound infection — 6%. There were no mortality in the series. Radiotherapy increased relapse-free survival without statistical confirmation. Conclusion. Total resection provides optimal results in patients with small convexity hyperostotic meningioma and no brain invasion. Resection of hyperostosis and expansive cranioplasty are preferable for large and giant convexity hyperostotic meningioma involving venous sinuses and / or the brain.
- 5 February 2025
- Published by Media Sphere Publishing Group in Burdenko's Journal of Neurosurgery
- Vol. 89 (1) , 109-115
Correction of the effect of direct oral and parenteral anticoagulants in hemorrhagic stroke
Background. Hemorrhagic stroke is associated with high risk of adverse outcome and follows intake of anticoagulants and antiplatelet agents in 25% of cases. The latest clinical guidelines of the Neurocritical Care Society for correction (reversal) of the effect of anticoagulants and antiplatelet agents in hemorrhagic stroke were published in 2016. Material and methods. In accordance with PRISMA recommendations, we reviewed the PubMed, eLibrary and UpToDate databases to a depth of 5 years and selected 48 articles. Results and discussion. Direct oral anticoagulants are currently common. To reverse their effect, one can use specific antidotes (idarucizumab is recommended for dabigatran, andexanet alfa (not yet registered In Russia) for factor Xa inhibitors (rivaroxaban, apixaban)) and combination of prothrombin complex concentrate and tranexamic acid. Protamine sulfate is antidote for unfractionated and low molecular weight heparins. Protamine sulfate completely inactivates unfractionated heparin, but it is less effective against low molecular weight heparin. It is characterized by high probability of anaphylactic reactions, especially after repeated administrations. The effectiveness of andexanet alpha and activated factor VII for reversing the effect of low molecular weight heparin is being studied. Fondaparinux sodium is used for heparin-induced thrombocytopenia. Protamine sulfate is ineffective for reversing the effect of fondaparinux. One can use prothrombin complex concentrate and andexanet alpha, but their effectiveness is unclear. Ciraparantag is being studied in clinical trials. Apparently, ciraparantag is highly effective as an antidote for various anticoagulants. Conclusion. Early hemostatic therapy and reversal of anticoagulant effects in patients with hemorrhagic stroke significantly reduce the risk of adverse outcomes. This problem is being studied. Regular literature review with creation of updated clinical guidelines is needed.
- 5 February 2025
- Published by Media Sphere Publishing Group in Burdenko's Journal of Neurosurgery
- Vol. 89 (1) , 109-115
Correction of the effect of direct oral and parenteral anticoagulants in hemorrhagic stroke
Background. Hemorrhagic stroke is associated with high risk of adverse outcome and follows intake of anticoagulants and antiplatelet agents in 25% of cases. The latest clinical guidelines of the Neurocritical Care Society for correction (reversal) of the effect of anticoagulants and antiplatelet agents in hemorrhagic stroke were published in 2016. Material and methods. In accordance with PRISMA recommendations, we reviewed the PubMed, eLibrary and UpToDate databases to a depth of 5 years and selected 48 articles. Results and discussion. Direct oral anticoagulants are currently common. To reverse their effect, one can use specific antidotes (idarucizumab is recommended for dabigatran, andexanet alfa (not yet registered In Russia) for factor Xa inhibitors (rivaroxaban, apixaban)) and combination of prothrombin complex concentrate and tranexamic acid. Protamine sulfate is antidote for unfractionated and low molecular weight heparins. Protamine sulfate completely inactivates unfractionated heparin, but it is less effective against low molecular weight heparin. It is characterized by high probability of anaphylactic reactions, especially after repeated administrations. The effectiveness of andexanet alpha and activated factor VII for reversing the effect of low molecular weight heparin is being studied. Fondaparinux sodium is used for heparin-induced thrombocytopenia. Protamine sulfate is ineffective for reversing the effect of fondaparinux. One can use prothrombin complex concentrate and andexanet alpha, but their effectiveness is unclear. Ciraparantag is being studied in clinical trials. Apparently, ciraparantag is highly effective as an antidote for various anticoagulants. Conclusion. Early hemostatic therapy and reversal of anticoagulant effects in patients with hemorrhagic stroke significantly reduce the risk of adverse outcomes. This problem is being studied. Regular literature review with creation of updated clinical guidelines is needed.
- 23 April 2024
- Published by Media Sphere Publishing Group in Burdenko's Journal of Neurosurgery
- Vol. 88 (6) , 47-53
Decolonization of autologous blood with cefuroxime during hardware reinfusion in neurosurgical patients
Autologous blood obtained during hardware reinfusion can be bacterially contaminated with skin microflora in most cases (up to 90%) regardless of the area of surgical intervention. Increased volume of washing solution for red blood cell management, white blood cell filtration and X-ray irradiation do not always provide complete decontamination. Objective. To analyze the effectiveness of adding cefuroxime to extracorporeal circuit during hardware blood reinfusion. Material and methods. The study included 50 patients with intracranial tumors. Hardware blood reinfusion was used due to baseline disease, blood supply to the neoplasm and high risk of intraoperative blood loss. All patients received perioperative antibiotic prophylaxis. We assessed the effectiveness of decontamination using microbiological control at all stages of the procedure. We used the XTRA Liva Nova complex autologous blood recovery system (Popt protocol), PALL Purecell RC2VAE leukocyte filters, BacT/ALERT 3D automatic microbiological analyzer and vials with FA Plus and FN Plus medium and adsorbent. X-ray irradiation of autologous erythrocytes was performed at a dose of 25 Gy (ARDOK-1 device). Results. Addition of cefuroxime 1.5 g to blood collection reservoir excluded bacterial growth in autologous blood samples from this reservoir in 100% of cases. At subsequent stages of blood processing, we isolated S. epidermidis, S. aureus, S. hominis, S. capitis, as well as Acinetobacter ursingii, Morganella morganii and Klebsiella aerogenes from some samples. Maximum bacterial contamination was observed at the stage of erythrocyte washing (34% of samples). After leukocyte filtration and blood irradiation, this value was 8%. Conclusion. Combination of all decontamination methods (erythrocyte washing in large volume of solution, leukocyte filtration and irradiation) together with adding cefuroxime into extracorporeal circuit excluded bacterial growth in 92% of samples of autologous erythrocytes.
- 23 April 2024
- Published by Media Sphere Publishing Group in Burdenko's Journal of Neurosurgery
- Vol. 88 (6) , 47-53
Decolonization of autologous blood with cefuroxime during hardware reinfusion in neurosurgical patients
Autologous blood obtained during hardware reinfusion can be bacterially contaminated with skin microflora in most cases (up to 90%) regardless of the area of surgical intervention. Increased volume of washing solution for red blood cell management, white blood cell filtration and X-ray irradiation do not always provide complete decontamination. Objective. To analyze the effectiveness of adding cefuroxime to extracorporeal circuit during hardware blood reinfusion. Material and methods. The study included 50 patients with intracranial tumors. Hardware blood reinfusion was used due to baseline disease, blood supply to the neoplasm and high risk of intraoperative blood loss. All patients received perioperative antibiotic prophylaxis. We assessed the effectiveness of decontamination using microbiological control at all stages of the procedure. We used the XTRA Liva Nova complex autologous blood recovery system (Popt protocol), PALL Purecell RC2VAE leukocyte filters, BacT/ALERT 3D automatic microbiological analyzer and vials with FA Plus and FN Plus medium and adsorbent. X-ray irradiation of autologous erythrocytes was performed at a dose of 25 Gy (ARDOK-1 device). Results. Addition of cefuroxime 1.5 g to blood collection reservoir excluded bacterial growth in autologous blood samples from this reservoir in 100% of cases. At subsequent stages of blood processing, we isolated S. epidermidis, S. aureus, S. hominis, S. capitis, as well as Acinetobacter ursingii, Morganella morganii and Klebsiella aerogenes from some samples. Maximum bacterial contamination was observed at the stage of erythrocyte washing (34% of samples). After leukocyte filtration and blood irradiation, this value was 8%. Conclusion. Combination of all decontamination methods (erythrocyte washing in large volume of solution, leukocyte filtration and irradiation) together with adding cefuroxime into extracorporeal circuit excluded bacterial growth in 92% of samples of autologous erythrocytes.
- 23 April 2024
- Published by Media Sphere Publishing Group in Burdenko's Journal of Neurosurgery
- Vol. 88 (6) , 103-109
Correction of the effect of vitamin K antagonists and antiplatelet agents in hemorrhagic stroke
Background. Hemorrhagic stroke (HS) is associated with high risk of mortality or disability. To date, up to 25% of HSs are associated with anticoagulants and antiplatelet agents. Early hemostatic therapy and correction of effect of antithrombotic drugs in patients with HS significantly reduce the risk of adverse outcomes. The latest international guidelines on this issue were presented almost 10 years ago. Material and methods. In accordance with the PRISMA recommendations, we reviewed the PubMed, eLibrary and UpToDate databases and identified 137 articles. Of these, 52 were enrolled as the most relevant. Results and discussion. Regarding correction of the effect of indirect anticoagulants, various researchers discuss the possibility of either individual dosing or injection of a fixed dose of 4- or 3-factor prothrombin complex (1000—2000 IU regardless of body weight and international normalized ratio). To correct the effect of antiplatelet agents, platelet transfusion and desmopressin are proposed. There is currently no evidence of safety and effectiveness of both methods in patients with HS. Conclusion. The optimal drug for correction of the effect of indirect anticoagulants is 4- or 3-factor prothrombin complex. In the last case, it is necessary to administer factor VIIa or fresh frozen plasma, as well as parenteral form of phytomenadione (vitamin K1) in all cases. The issue of correction of the effects of antiplatelet agents remains open. Regular analysis of available data with updating the guidelines for correction of the effect of anticoagulants and antiplatelet agents in HS is necessary.
- 23 April 2024
- Published by Media Sphere Publishing Group in Burdenko's Journal of Neurosurgery
- Vol. 88 (6) , 103-109
Correction of the effect of vitamin K antagonists and antiplatelet agents in hemorrhagic stroke
Background. Hemorrhagic stroke (HS) is associated with high risk of mortality or disability. To date, up to 25% of HSs are associated with anticoagulants and antiplatelet agents. Early hemostatic therapy and correction of effect of antithrombotic drugs in patients with HS significantly reduce the risk of adverse outcomes. The latest international guidelines on this issue were presented almost 10 years ago. Material and methods. In accordance with the PRISMA recommendations, we reviewed the PubMed, eLibrary and UpToDate databases and identified 137 articles. Of these, 52 were enrolled as the most relevant. Results and discussion. Regarding correction of the effect of indirect anticoagulants, various researchers discuss the possibility of either individual dosing or injection of a fixed dose of 4- or 3-factor prothrombin complex (1000—2000 IU regardless of body weight and international normalized ratio). To correct the effect of antiplatelet agents, platelet transfusion and desmopressin are proposed. There is currently no evidence of safety and effectiveness of both methods in patients with HS. Conclusion. The optimal drug for correction of the effect of indirect anticoagulants is 4- or 3-factor prothrombin complex. In the last case, it is necessary to administer factor VIIa or fresh frozen plasma, as well as parenteral form of phytomenadione (vitamin K1) in all cases. The issue of correction of the effects of antiplatelet agents remains open. Regular analysis of available data with updating the guidelines for correction of the effect of anticoagulants and antiplatelet agents in HS is necessary.
- 23 April 2024
- Published by Media Sphere Publishing Group in Burdenko's Journal of Neurosurgery
- Vol. 88 (5) , 69-76
Short-lasting tentorial herniation may cause cortical blindness. A case report and systematic literature review
Introduction. Cortical blindness occurs with bilateral damage to the visual cortex. It can be caused by various reasons, including the posterior cerebral arteries stroke due to the tentorial herniation. Material and methods. A case of a 40-year-old patient with a large right-sided sphenoidal meningioma. A systematic review on the problem of cortical blindness after tentorial herniation according to the PRISMA guideline. Results. Subtotal removal of dense meningioma. At night after the operation, there was an acute headache, then a coma. Immediately dehydration therapy, tracheal intubation, mechanical ventilation. CT scan showed a small hemorrhage in the tumor bed and subarachnoid space, brain edema and dislocation. After 53 minutes, ventricular drainage was installed, intracranial pressure was normal and ranged from 6 to 14 mmHg. After sedation withdrawal, cortical blindness was detected, which did not regress for 1.5 years. There are no other neurological symptoms, the patient walks, serves herself. Radiation therapy in a total of 54 Gy for the remainder of the grade 1 meningioma ensured tumor control. Discussion. The time window for restoration of the cerebral blood flow, according to the European Stroke Organization guidelines, is 4.5 hours. In this case, compression of the posterior cerebral arteries lasted less than 53 minutes, however, irreversible ischemia developed in their territory; the outcome on the modified Rankine scale was 4 points. Similar cases are not described in the literature. Conclusion. Patients should be warned about even the non-obvious risks of neurosurgical intervention, since even timely measures taken do not always avoid complications.
- 23 April 2024
- Published by Media Sphere Publishing Group in Burdenko's Journal of Neurosurgery
- Vol. 88 (5) , 69-76
Short-lasting tentorial herniation may cause cortical blindness. A case report and systematic literature review
Introduction. Cortical blindness occurs with bilateral damage to the visual cortex. It can be caused by various reasons, including the posterior cerebral arteries stroke due to the tentorial herniation. Material and methods. A case of a 40-year-old patient with a large right-sided sphenoidal meningioma. A systematic review on the problem of cortical blindness after tentorial herniation according to the PRISMA guideline. Results. Subtotal removal of dense meningioma. At night after the operation, there was an acute headache, then a coma. Immediately dehydration therapy, tracheal intubation, mechanical ventilation. CT scan showed a small hemorrhage in the tumor bed and subarachnoid space, brain edema and dislocation. After 53 minutes, ventricular drainage was installed, intracranial pressure was normal and ranged from 6 to 14 mmHg. After sedation withdrawal, cortical blindness was detected, which did not regress for 1.5 years. There are no other neurological symptoms, the patient walks, serves herself. Radiation therapy in a total of 54 Gy for the remainder of the grade 1 meningioma ensured tumor control. Discussion. The time window for restoration of the cerebral blood flow, according to the European Stroke Organization guidelines, is 4.5 hours. In this case, compression of the posterior cerebral arteries lasted less than 53 minutes, however, irreversible ischemia developed in their territory; the outcome on the modified Rankine scale was 4 points. Similar cases are not described in the literature. Conclusion. Patients should be warned about even the non-obvious risks of neurosurgical intervention, since even timely measures taken do not always avoid complications.